Patient Chart Dynamix™ is an independent, data-driven service that unveils real-world patient management trends via large-scale patient chart audits. Designed to quantify practice patterns, measure ...

Remegen Co. Ltd. emerged as a surprise challenger in the generalized myasthenia gravis space, unveiling positive phase III data of its China-approved lupus drug, telitacicept (RCT-18; Tai’ai), in the ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty involvement and treatment with immunosuppressive medications. A detailed history and ...

Saphnelo (anifrolumab-fnia) is a prescription drug used to treat systemic lupus erythematosus (SLE). It is given as an intravenous (IV) infusion by a healthcare professional. Saphnelo is used to ...

The Lupus Foundation of America is profoundly concerned by the reorganization and significant staff reductions taking place at the U.S. Department of Health and Human Services (HHS) in addition to ...

MANILA, Philippines — Host-actress Kris Aquino revealed she has been suffering from a fever for two weeks as a result of a Lupus flare alongside her many autoimmune diseases. Kris recently ...

One clip showed Kris’ fever reaching more than 38 degrees Celsius. Kris said that she has been experiencing a lupus flare for “more than two weeks.” "This is MY NOW… i wanted you to see the pain and ...

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body that fights off disease and infections. Some of the most common symptoms ...

It can affect many parts of the body. Cutaneous lupus mainly affects the skin. Discoid lupus causes a disc-shaped rash. Subacute cutaneous lupus causes widespread skin lesions. Each type has ...

Unlike an earlier study, which was restricted to patients with systemic lupus erythematosus (SLE), the most recent trial enrolled patients with the most common forms of CLE, which are discoid ...